You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelin Protein

Showing 1 - 25 of 8,937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Central and Peripheral Nervous System Changes as Markers of

Completed
  • Multiple Sclerosis
  • +7 more
    • Sønderborg, Jylland, Denmark
      Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
    Oct 13, 2021

    Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

    Not yet recruiting
    • Monoclonal Gammopathy of Uncertain Significance
    • Zanubrutinib Oral Product
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Jul 6, 2023

    Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of

    Not yet recruiting
    • Acute Demyelinating Syndrome
    • Immediate Azathioprine (1st attack)
    • +2 more
    • Besançon, France
    • +8 more
    Sep 14, 2022

    European Study of Prodromal iNPH

    Not yet recruiting
    • Normal Pressure Hydrocephalus
    • Hydrocephalus
    • Shunt surgery
    • Kuopio, Finland
    • +6 more
    Jun 18, 2023

    Acute Optic Neuritis Network:International Study That

    Recruiting
    • Demyelinating Diseases
    • +4 more
    • non-interventional study
    • Aurora, Colorado
    • +25 more
    Oct 31, 2022

    Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)

    Withdrawn
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • (no location specified)
    Nov 2, 2021

    Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,

    Recruiting
    • Adrenoleukodystrophy
    • +3 more
    • Blood sample collection
    • Le Kremlin-Bicêtre, France
    • +1 more
    Oct 10, 2022

    CNS Inflammatory Demyelinating Diseases

    Not yet recruiting
    • Multiple Sclerosis
    • +4 more
    • Intravenous steroid
    • (no location specified)
    Nov 29, 2021

    Neurocognitive Disorders, Surgery-Complications, Critical Illness Trial in Lublin (Cerebrolysin)

    Recruiting
    • Neurocognitive Disorders
    • +4 more
    • Lublin, Poland
      Medical University
    May 16, 2023

    Chronic Spinal Cord Injury Trial in United States (AXER-204, Placebo)

    Completed
    • Chronic Spinal Cord Injury
    • Los Angeles, California
    • +5 more
    Aug 16, 2022

    Dexmedetomidine on Cognitive Outcome and Brain Injury Markers

    Completed
    • Cognitive Dysfunction
    • Dexmedetomidine Infusion
    • Propofol based general anesthesia
    • Lublin, Lubelskie, Poland
      Michał Kowalczyk
    Oct 23, 2022

    Myelin Imaging in Concussed High School Football Players

    Terminated
    • Traumatic Brain Injury
    • McDESPOT
    • Hollywood, Florida
      Memorial Healthcare System
    Sep 23, 2020

    Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD) Trial in Worldwide (Rozanolixizumab, Placebo)

    Recruiting
    • Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
    • Scottsdale, Arizona
    • +43 more
    Feb 2, 2023

    CMT1A Trial in France (EllaOne, EllaOne )

    Terminated
    • CMT1A
    • Besançon, France
    • +4 more
    Jul 20, 2022

    Infant Nutrition, Cognitive Development Trial (Experimental formula, Control Formula)

    Not yet recruiting
    • Infant Nutrition
    • Cognitive Development
    • Experimental formula
    • Control Formula
    • (no location specified)
    Jun 22, 2022

    Krabbe Disease Trial in Buffalo

    Recruiting
    • Krabbe Disease
      • Buffalo, New York
        State University of New York at Buffalo
      Apr 17, 2022

      Healthy Participants Trial in Toronto (Lucid-21-302, Placebo)

      Recruiting
      • Healthy Participants
      • Toronto, Ontario, Canada
        Biopharma Services Incorporated
      Apr 6, 2023

      Prognostic Factors of Gullian Barrie Syndrome Outcome

      Completed
      • Guillain-Barre Syndrome
      • plasmapheresis
      • Assuit, Assiut, Egypt
        Assiut university
      Dec 7, 2022

      Multiple Sclerosis Trial in Derby (Homologous booster, Heterologous booster)

      Recruiting
      • Multiple Sclerosis
      • Homologous booster
      • Heterologous booster
      • Derby, Connecticut
        Griffin Hospital
      Jan 23, 2022

      Sensitivity and Specificity of TSA-CBA for Autoantibodies

      Recruiting
      • NMO Spectrum Disorder
      • +6 more
      • CBA-TSA
      • Beijing, Beijing, China
        Beijing Tiantan Hospital
      Jun 8, 2022

      Neurofibromatosis 1 Trial in Cincinnati (N-Acetyl cysteine, Placebo)

      Recruiting
      • Neurofibromatosis 1
      • N-Acetyl cysteine
      • Placebo
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      Feb 24, 2022

      Multiple Sclerosis Trial in Philadelphia (N-acetyl Cysteine)

      Enrolling by invitation
      • Multiple Sclerosis
      • N-acetyl Cysteine
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Aug 26, 2022

      Prolapse Genital Trial in Rennes (biopsy)

      Recruiting
      • Prolapse Genital
      • biopsy
      • Rennes, Bretagne, France
        Rennes University Hospital
      Nov 8, 2022

      Treatment Resistant Depression Trial in Chieti (Accelerated Repetitive Transcranial Magnetic Stimulation)

      Recruiting
      • Treatment Resistant Depression
      • Accelerated Repetitive Transcranial Magnetic Stimulation
      • Chieti, Italy
        ITAB
      Apr 3, 2023

      Plasma Amino Acid Appearance and Disappearance, Postprandial Metabolic Events Trial (Pea protein concentrate, Pea protein

      Not yet recruiting
      • Plasma Amino Acid Appearance and Disappearance
      • Postprandial Metabolic Events
      • Pea protein concentrate
      • +3 more
      • (no location specified)
      Nov 30, 2023